Zhejiang
Zhejiang
Zhejiang, Hangzhou, China21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 3 | 2026-10-05 | NCT04224493 | |
| Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Not yet recruiting | Phase 3 | 2026-09-25 | NCT07835152 | |
| VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-22 | NCT07772934 | |
| Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-16 | NCT07792681 | |
| A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors | Advanced Malignant Solid Tumors | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07806175 | |
| Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Not yet recruiting | Phase 3 | 2026-08-21 | NCT07779538 | |
| Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration | Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | Recruiting | Phase 2 | 2026-08-20 | NCT07776522 | |
| A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, gastric cancer, gastric neoplasm, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, stomach disorder | Recruiting | Phase 1 | 2026-08-13 | NCT07066657 | |
| Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002 | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-08-04 | NCT06832982 | |
| A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-03-06 | NCT07455188 | |
| TMS for Improving Cognitive Function in Bipolar Disorder | Bipolar and Related Disorders, Cognition Disorders, Cognitive Dysfunction, bipolar disorder, cognitive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-02-17 | NCT07414147 | |
| A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-01-09 | NCT07330544 | |
| Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Not stated | 2026-01-08 | NCT07326150 | |
| Biomechanical Study of Lever Positioning Manipulation on Scoliosis | Spinal Curvatures, bone disorder, musculoskeletal system disorder, scoliosis, vertebral column disorder | Not yet recruiting | Not applicable | 2026-01-08 | NCT07325045 | |
| A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects | Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, digestive system disorder, digestive system neoplasm, neoplasm | Recruiting | Phase 1 | 2026-01-06 | NCT07319364 | |
| Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain | Chronic Cancer Pain; Quality of Life | Recruiting | Not applicable | 2025-12-30 | NCT07308951 | |
| Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer | gastric adenocarcinoma | Recruiting | Phase 3 | 2025-12-17 | NCT07029269 | |
| Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer | Pancreatic Cancer Non-resectable | Active, not recruiting | Not stated | 2025-12-09 | NCT07271823 | |
| An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2025-11-24 | NCT06238401 | |
| Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery | Cancer Surgery; Dexmedetomidine; Elderly; Long-Term Survivors | Recruiting | Not applicable | 2025-07-31 | NCT06030804 | |
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer | Efficacy and Safety | Recruiting | Phase 1 / Phase 2 | 2024-12-04 | NCT04518501 |